The Effect of Pirfenidone on the Prescription of Antibiotics and Antitussive Drugs in Patients With Idiopathic Pulmonary Fibrosis: A Post Hoc Exploratory Analysis of Phase III Clinical Trial

Chest. 2021 Oct;160(4):1372-1376. doi: 10.1016/j.chest.2021.05.058. Epub 2021 Jun 5.
No abstract available

Publication types

  • Clinical Trial, Phase III
  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Anti-Bacterial Agents / therapeutic use*
  • Antifibrotic Agents / therapeutic use*
  • Antitussive Agents / therapeutic use*
  • Disease Progression
  • Female
  • Humans
  • Idiopathic Pulmonary Fibrosis / drug therapy*
  • Male
  • Middle Aged
  • Polypharmacy*
  • Pyridones / therapeutic use*
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Antifibrotic Agents
  • Antitussive Agents
  • Pyridones
  • pirfenidone